Senator Lee’s New and Improved Biosimilar Red Tape Elimination Act
Jeffrey A. Singer Last November, I wrote about Senator Mike Lee’s (R‑UT) effort to reduce pharmaceutical expenditures by
The Same First Amendment That Protects Lorie Smith Protects the Target Corporation
Walter Olson Seven conservative state attorneys general led by Indiana’s Todd Rokita have sent a letter to the
Can Managed Care Reel in Idaho’s Spiraling Medicaid Costs?
Marc Joffe Recent years have brought significant changes to Idaho public finances. In addition to rapid increases
New Jones Act Ship Offers Cautionary Tale of Shipbuilding Protectionism
Colin Grabow Earlier this week an unusual event took place: a U.S. shipyard delivered an oceangoing merchant ship.
Government Power Is Just as Dangerous in “Private” Hands
Thomas A. Berry In 2020, Congress passed the Horseracing Integrity and Safety Act (HISA). HISA established a private
American Compass Dystopia: “Rebuilding” American Capitalism
Norbert Michel A few weeks ago, American Compass released Rebuilding American Capitalism, A Handbook for Conservative Policymakers. After
FDA Finally Allows OTC Access to One Brand of “Minipill”—A Mini‐step in the Right Direction
Jeffrey A. Singer The Food and Drug Administration announced this morning that it has granted marketing approval
The Fed Should Continue to Hold Steady
Jai Kedia From the moment the Fed announced its decision last month to hold target rates steady,
My Washington Post Letter to the Editor about Portugal’s Drug Decriminalization
Jeffrey A. Singer On July 7, the Washington Post ran a story by Anthony Faiola and Catarina Fernandes
If the FTC Gets Its Way, Could This Be the Last Prime Day?
Jennifer Huddleston For the millions of consumers who enjoy the benefits of their Amazon Prime membership, Amazon’s